Exact Mass: 315.2674

Exact Mass Matches: 315.2674

Found 141 metabolites which its exact mass value is equals to given mass value 315.2674, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Decanoylcarnitine (C10)

(3R)-3-(decanoyloxy)-4-(trimethylazaniumyl)butanoate

C17H33NO4 (315.2409)


Decanoylcarnitine is a member of the class of compounds known as acylcarnitines. More specifically, it is a decanoic acid ester of carnitine. Acylcarnitines were first discovered in the 1940s (PMID: 13825279 ). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Decanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine decanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494 ). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular decanoylcarnitine is elevated in the blood or plasma of individuals with obesity in adolescence (PMID: 26910390 ). It is also decreased in the blood or plasma of individuals with adolescent idiopathic scoliosis (PMID: 26928931 ). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279 ). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. Acylcarnitine useful in the diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency deficiencyoxidation disorders.(PMID: 12385891) [HMDB]

   

CID 5281853

CID 5281853

C20H33N3 (315.2674)


   

Bremazocine

Bremazocine

C20H29NO2 (315.2198)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Dehydrophytosphingosine

Dehydrophytosphingosine (not validated, isomer of 1677)

C18H37NO3 (315.2773)


Dehydrophytosphingosine is found in pulses. Dehydrophytosphingosine is present in soybean phospholipids. Present in soybean phospholipids. Dehydrophytosphingosine is found in pulses.

   

6-Methylnonanoylcarnitine

3-[(6-methylnonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO4 (315.2409)


6-Methylnonanoylcarnitine is an acylcarnitine. More specifically, it is an 6-methylnonanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-Methylnonanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-Methylnonanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Methylnonanoylcarnitine

3-[(5-methylnonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO4 (315.2409)


5-Methylnonanoylcarnitine is an acylcarnitine. More specifically, it is an 5-methylnonanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Methylnonanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Methylnonanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

8-Methylnonanoylcarnitine

3-[(8-methylnonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO4 (315.2409)


8-Methylnonanoylcarnitine is an acylcarnitine. More specifically, it is an 8-methylnonanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 8-Methylnonanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 8-Methylnonanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Methylnonanoylcarnitine

3-[(7-methylnonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO4 (315.2409)


7-Methylnonanoylcarnitine is an acylcarnitine. More specifically, it is an 7-methylnonanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-Methylnonanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 7-Methylnonanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Methylnonanoylcarnitine

3-[(4-methylnonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO4 (315.2409)


4-Methylnonanoylcarnitine is an acylcarnitine. More specifically, it is an 4-methylnonanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Methylnonanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Methylnonanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Methylnonanoylcarnitine

3-[(3-methylnonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO4 (315.2409)


3-Methylnonanoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylnonanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methylnonanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Methylnonanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-Myristoyl Serine

3-hydroxy-2-tetradecanamidopropanoic acid

C17H33NO4 (315.2409)


N-myristoyl serine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Serine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Serine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Serine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

(-)-Bremazocine

1-ethyl-10-[(1-hydroxycyclopropyl)methyl]-13,13-dimethyl-10-azatricyclo[7.3.1.0^{2,7}]trideca-2(7),3,5-trien-4-ol

C20H29NO2 (315.2198)


   

(1S,2R,3S,7R,10S,13S,14R)-1-Methyl-14-propan-2-yl-2-propyl-12-azapentacyclo[8.6.0.02,13.03,7.07,12]hexadecane

(1S,2R,3S,7R,10S,13S,14R)-1-Methyl-14-propan-2-yl-2-propyl-12-azapentacyclo[8.6.0.02,13.03,7.07,12]hexadecane

C22H37N (315.2926)


   

Pamaquine

8-((4-(Diethylamino)-1-methylbutyl)amino)-6-methoxyquinoline

C19H29N3O (315.2311)


   

Piperidine, 1-(4-(1-methyl-1-(4-methylcyclohexyl)ethoxy)phenyl)-, cis-

Piperidine, 1-(4-(1-methyl-1-(4-methylcyclohexyl)ethoxy)phenyl)-, cis-

C21H33NO (315.2562)


   

(9R,10S)-dihydroxystearate

9,10-Dihydroxyoctadecanoic acid

C18H35O4- (315.2535)


(9r,10s)-dihydroxystearate, also known as 9,10-dihydroxyoctadecanoate, is a member of the class of compounds known as long-chain fatty acids. Long-chain fatty acids are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms (9r,10s)-dihydroxystearate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). (9r,10s)-dihydroxystearate can be found in a number of food items such as pulses, sorghum, yautia, and european plum, which makes (9r,10s)-dihydroxystearate a potential biomarker for the consumption of these food products.

   

SCHEMBL18891611

SCHEMBL18891611

C21H33NO (315.2562)


   

N-Formyl-7-amino-11-cycloamphilectene

N-Formyl-7-amino-11-cycloamphilectene

C21H33NO (315.2562)


   

3-(2-heptylcyclopropyl)-N-phenylethylpropanamide

3-(2-heptylcyclopropyl)-N-phenylethylpropanamide

C21H33NO (315.2562)


   

17β-Hydroxy-androstano[3,2-c]isoxazole

17β-Hydroxy-androstano[3,2-c]isoxazole

C20H29NO2 (315.2198)


   

N-(4-Hydroxyphenethyl)-2,4-dodecadienamid

N-(4-Hydroxyphenethyl)-2,4-dodecadienamid

C20H29NO2 (315.2198)


   

Alkaloid GB13

Alkaloid GB13

C20H29NO2 (315.2198)


   
   

(1S*,3S*,4R*,7S*,8S*,12S*,13S*)-7-formamidocycloamphilect-11(20)-ene

(1S*,3S*,4R*,7S*,8S*,12S*,13S*)-7-formamidocycloamphilect-11(20)-ene

C21H33NO (315.2562)


   

podopetaline monohydrochloride

podopetaline monohydrochloride

C20H33N3 (315.2674)


   

(E,E)-N-(4-Hydroxyphenethyl)-2,4-dodecadienamide

(E,E)-N-(4-Hydroxyphenethyl)-2,4-dodecadienamide

C20H29NO2 (315.2198)


   

11,12-didehydro-ormosanine|Panamin

11,12-didehydro-ormosanine|Panamin

C20H33N3 (315.2674)


   
   

caldaphnidine G

caldaphnidine G

C21H33NO (315.2562)


   

(1R*,3S*,4R*,7S*,8S*,12S*,13S*)-7-formamidoamphilecta-11(20),14-diene

(1R*,3S*,4R*,7S*,8S*,12S*,13S*)-7-formamidoamphilecta-11(20),14-diene

C21H33NO (315.2562)


   

cavernene B

cavernene B

C21H33NO (315.2562)


   

(1(14)-E,3S,4R,7S,8S,11R,12S,13R)-7-formamidoisoneoamphilecta-1(14),15-diene|7-formamidoisoneoamphilecta-1(14),15-diene

(1(14)-E,3S,4R,7S,8S,11R,12S,13R)-7-formamidoisoneoamphilecta-1(14),15-diene|7-formamidoisoneoamphilecta-1(14),15-diene

C21H33NO (315.2562)


   

Leptophyllin A

Leptophyllin A

C18H37NO3 (315.2773)


   

(1S*,3S*,4R*,7S*,8S*,12S*,13S*)-7-formamidoamphilecta-11(20),15-diene

(1S*,3S*,4R*,7S*,8S*,12S*,13S*)-7-formamidoamphilecta-11(20),15-diene

C21H33NO (315.2562)


   

(2E,4E)-N-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienamide

NCGC00380344-01!(2E,4E)-N-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienamide

C20H29NO2 (315.2198)


   

Decanoylcarnitine

Decanoylcarnitine

C17H33NO4 (315.2409)


   

(2E,4E)-N-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienamide

(2E,4E)-N-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienamide

C20H29NO2 (315.2198)


   

Decanoyl-L-carnitine

Decanoyl-L-carnitine

C17H33NO4 (315.2409)


CONFIDENCE standard compound; INTERNAL_ID 249

   

C13DEA

N,N-Bis(2-hydroxyethyl)tetradecanamide

C18H37NO3 (315.2773)


Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); May be an alkyl homologue; Digitised from figure: approximate intensities

   

Dehydrophytosphingosine (not validated, isomer of 1677)

Dehydrophytosphingosine (not validated, isomer of 1677)

C18H37NO3 (315.2773)


Annotation level-3

   

Dehydrophytosphingosine (not validated, isomer of 1679)

Dehydrophytosphingosine (not validated, isomer of 1679)

C18H37NO3 (315.2773)


Annotation level-3

   

(2E,4E)-N-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienamide [IIN-based on: CCMSLIB00000846683]

NCGC00380344-01!(2E,4E)-N-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienamide [IIN-based on: CCMSLIB00000846683]

C20H29NO2 (315.2198)


   

(2E,4E)-N-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienamide [IIN-based: Match]

NCGC00380344-01!(2E,4E)-N-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienamide [IIN-based: Match]

C20H29NO2 (315.2198)


   

Decanoyl-carnitine; AIF; CE0; CorrDec

Decanoyl-carnitine; AIF; CE0; CorrDec

C17H33NO4 (315.2409)


   

Decanoyl-carnitine; AIF; CE10; CorrDec

Decanoyl-carnitine; AIF; CE10; CorrDec

C17H33NO4 (315.2409)


   

Decanoyl-carnitine; AIF; CE30; CorrDec

Decanoyl-carnitine; AIF; CE30; CorrDec

C17H33NO4 (315.2409)


   

Decanoyl-carnitine; AIF; CE0; MS2Dec

Decanoyl-carnitine; AIF; CE0; MS2Dec

C17H33NO4 (315.2409)


   

Decanoyl-carnitine; AIF; CE10; MS2Dec

Decanoyl-carnitine; AIF; CE10; MS2Dec

C17H33NO4 (315.2409)


   

Decanoyl-carnitine; AIF; CE30; MS2Dec

Decanoyl-carnitine; AIF; CE30; MS2Dec

C17H33NO4 (315.2409)


   

L-Hexanoylcarnitine n-butyl ester

L-Hexanoylcarnitine n-butyl ester

C17H33NO4 (315.2409)


   

Dehydrophytosphingosine

4R-hydroxysphing-8E-enine

C18H37NO3 (315.2773)


   

6-hydroxysphingosine

6-hydroxysphing-4E-enine

C18H37NO3 (315.2773)


   

4R-hydroxy-sphing-8Z-enine

4R-hydroxy-sphing-8Z-enine

C18H37NO3 (315.2773)


   

(2E,4E)-N-[2-(4-Hydroxyphenyl)ethyl]-2,4-dodecadienamide

(2E,4E)-N-[2-(4-Hydroxyphenyl)ethyl]-2,4-dodecadienamide

C20H29NO2 (315.2198)


   

CAR 10:0

3-(decanoyloxy)-4-(trimethylazaniumyl)butanoate

C17H33NO4 (315.2409)


   

NA 20:6;O

Dodeca-2E,4E-dienoic acid 4-hydroxy-2-phenylethylamide

C20H29NO2 (315.2198)


   

SPB 19:0;O2

17-Methyloctadecasphinganine

C19H41NO2 (315.3137)


   

SPB 18:1;O3

4R-hydroxy-sphing-8Z-enine

C18H37NO3 (315.2773)


   

Tetrabutylammonium fluoride trihydrate

Tetrabutylammonium fluoride trihydrate

C16H42FNO3 (315.3149)


   

N,N-bis(2-hydroxypropyl)dodecanamide

N,N-bis(2-hydroxypropyl)dodecanamide

C18H37NO3 (315.2773)


   

4-Piperidinecarboxamide,4-(cyclohexylamino)-1-(phenylmethyl)-

4-Piperidinecarboxamide,4-(cyclohexylamino)-1-(phenylmethyl)-

C19H29N3O (315.2311)


   

N-[2-[[2-[[2-[(2-aminoethyl)amino]ethyl]amino]ethyl]amino]ethyl]octanamide

N-[2-[[2-[[2-[(2-aminoethyl)amino]ethyl]amino]ethyl]amino]ethyl]octanamide

C16H37N5O (315.2998)


   

N-Myristoyl-L-serine

N-Myristoyl-L-serine

C17H33NO4 (315.2409)


   

Boc-12-Ado-OH

Boc-12-Ado-OH

C17H33NO4 (315.2409)


   

3-(2-phenyl-2-Cyclopentyl-2-hydroxyethoxy)quinuclidine

3-(2-phenyl-2-Cyclopentyl-2-hydroxyethoxy)quinuclidine

C20H29NO2 (315.2198)


   

2-[(3-benzyl-4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl)oxy]-N,N-dimethylethanamine

2-[(3-benzyl-4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl)oxy]-N,N-dimethylethanamine

C21H33NO (315.2562)


   

pamaquine

pamaquine

C19H29N3O (315.2311)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

1-O-Hexadecyl-2-desoxy-2-amino-sn-glycerol

1-O-Hexadecyl-2-desoxy-2-amino-sn-glycerol

C19H41NO2 (315.3137)


   

17beta-Hydroxy-androstano[3,2-c]isoxazole

17beta-Hydroxy-androstano[3,2-c]isoxazole

C20H29NO2 (315.2198)


   

N-Dodecylphthalimide

N-Dodecylphthalimide

C20H29NO2 (315.2198)


   

(9S,10S)-9,10-dihydroxyoctadecanoate

(9S,10S)-9,10-dihydroxyoctadecanoate

C18H35O4- (315.2535)


Conjugate base of (9S,10S)-9,10-dihydroxyoctadecanoic acid.

   

(9R,10S)-dihydroxystearate

(9R,10S)-dihydroxystearate

C18H35O4- (315.2535)


   

(2S,3S,4R)-2-aminooctadec-8-ene-1,3,4-triol

(2S,3S,4R)-2-aminooctadec-8-ene-1,3,4-triol

C18H37NO3 (315.2773)


   

(2S,3R,6R)-2-Amino-4-octadecene-1,3,6-triol

(2S,3R,6R)-2-Amino-4-octadecene-1,3,6-triol

C18H37NO3 (315.2773)


   

(3aS,6R,7aS)-6-ethyl-N-[(2S)-2-ethyl-1-prop-1-en-2-ylcyclopropyl]-1-oxo-2,3,3a,6,7,7a-hexahydroindene-4-carboxamide

(3aS,6R,7aS)-6-ethyl-N-[(2S)-2-ethyl-1-prop-1-en-2-ylcyclopropyl]-1-oxo-2,3,3a,6,7,7a-hexahydroindene-4-carboxamide

C20H29NO2 (315.2198)


   

6-Methylnonanoylcarnitine

6-Methylnonanoylcarnitine

C17H33NO4 (315.2409)


   

5-Methylnonanoylcarnitine

5-Methylnonanoylcarnitine

C17H33NO4 (315.2409)


   

8-Methylnonanoylcarnitine

8-Methylnonanoylcarnitine

C17H33NO4 (315.2409)


   

7-Methylnonanoylcarnitine

7-Methylnonanoylcarnitine

C17H33NO4 (315.2409)


   

4-Methylnonanoylcarnitine

4-Methylnonanoylcarnitine

C17H33NO4 (315.2409)


   

3-Methylnonanoylcarnitine

3-Methylnonanoylcarnitine

C17H33NO4 (315.2409)


   
   

daphnane

daphnane

C22H37N (315.2926)


A tetracyclic terpene alkaloid and the parent compound of the daphnane subgroup of the squalene-derived Daphniphyllium alkaloids. D009676 - Noxae > D002273 - Carcinogens D000970 - Antineoplastic Agents

   

Halisphingosine A

Halisphingosine A

C18H37NO3 (315.2773)


A sphingoid that is octadec-7-ene substituted by an amino group at position 2 and hydroxy groups at positions 1, 3 and 6 (the 2R,3R,6R,7Z stereoisomer). It is isolated from the marine sponge Haliclona.

   

3,18-Dihydroxystearate

3,18-Dihydroxystearate

C18H35O4- (315.2535)


An omega-hydroxy fatty acid anion that is the conjugate base of 3,18-dihydroxystearic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

12,18-Dihydroxyoctadecanoate

12,18-Dihydroxyoctadecanoate

C18H35O4- (315.2535)


A hydroxy fatty acid anion that is the conjugate base of 12,18-dihydroxyoctadecanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5S)-1-heptyl-5-(2-methylpropyl)-N-phenyl-4,5-dihydroimidazol-2-amine

(5S)-1-heptyl-5-(2-methylpropyl)-N-phenyl-4,5-dihydroimidazol-2-amine

C20H33N3 (315.2674)


   

(9R,10R)-9,10-dihydroxyoctadecanoate

(9R,10R)-9,10-dihydroxyoctadecanoate

C18H35O4- (315.2535)


   

(2R)-2-hydroperoxyoctadecanoate

(2R)-2-hydroperoxyoctadecanoate

C18H35O4- (315.2535)


   

Alanine, N-methyl-N-methoxycarbonyl-, undecyl ester

Alanine, N-methyl-N-methoxycarbonyl-, undecyl ester

C17H33NO4 (315.2409)


   

(9S,10R)-dihydroxyoctadecanoate

(9S,10R)-dihydroxyoctadecanoate

C18H35O4- (315.2535)


A hydroxy fatty acid anion that is the conjugate base of (9S,10R)-dihydroxyoctadecanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

10,13-Dihydroxyoctadecanoate

10,13-Dihydroxyoctadecanoate

C18H35O4- (315.2535)


   

(3R)-3-decanoyloxy-4-[dimethyl(trideuteriomethyl)azaniumyl]butanoate

(3R)-3-decanoyloxy-4-[dimethyl(trideuteriomethyl)azaniumyl]butanoate

C17H33NO4 (315.2409)


   

2-Aminononadecane-1,3-diol

2-Aminononadecane-1,3-diol

C19H41NO2 (315.3137)


   

N-(1,3-dihydroxyhexadecan-2-yl)acetamide

N-(1,3-dihydroxyhexadecan-2-yl)acetamide

C18H37NO3 (315.2773)


   

N-(1,3-dihydroxynonan-2-yl)nonanamide

N-(1,3-dihydroxynonan-2-yl)nonanamide

C18H37NO3 (315.2773)


   

N-(1,3-dihydroxydodecan-2-yl)hexanamide

N-(1,3-dihydroxydodecan-2-yl)hexanamide

C18H37NO3 (315.2773)


   

N-(1,3-dihydroxydecan-2-yl)octanamide

N-(1,3-dihydroxydecan-2-yl)octanamide

C18H37NO3 (315.2773)


   

N-(1,3-dihydroxytetradecan-2-yl)butanamide

N-(1,3-dihydroxytetradecan-2-yl)butanamide

C18H37NO3 (315.2773)


   

N-(1,3-dihydroxypentadecan-2-yl)propanamide

N-(1,3-dihydroxypentadecan-2-yl)propanamide

C18H37NO3 (315.2773)


   

N-(1,3-dihydroxyoctan-2-yl)decanamide

N-(1,3-dihydroxyoctan-2-yl)decanamide

C18H37NO3 (315.2773)


   

N-(1,3-dihydroxytridecan-2-yl)pentanamide

N-(1,3-dihydroxytridecan-2-yl)pentanamide

C18H37NO3 (315.2773)


   

N-(1,3-dihydroxyundecan-2-yl)heptanamide

N-(1,3-dihydroxyundecan-2-yl)heptanamide

C18H37NO3 (315.2773)


   

O-Decanoyl-L-carnitine

O-Decanoyl-L-carnitine

C17H33NO4 (315.2409)


An O-acyl-L-carnitine that is L-carnitine having decanoyl as the acyl substituent.

   

CID 5281853

CID 5281853

C20H33N3 (315.2674)


   

4-hydroxy-8cis-sphingenine

4-hydroxy-8cis-sphingenine

C18H37NO3 (315.2773)


   

9,10-Dihydroxystearate

9,10-Dihydroxystearate

C18H35O4- (315.2535)


A long-chain fatty acid anion that is the conjugate base of 9,10-dihydroxystearic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

O-decanoylcarnitine

O-decanoylcarnitine

C17H33NO4 (315.2409)


An O-acylcarnitine compound having decanoyl as the acyl substituent.

   

6-hydroxysphing-4E-enine

6-hydroxysphing-4E-enine

C18H37NO3 (315.2773)


A sphingoid that is sphingosine with an additional hydroxy group at position 6

   

Sphingosine (d19:0)

SPH(d19:0)

C19H41NO2 (315.3137)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   

Hydroxysphingosine

Hydroxysphingosine

C18H37NO3 (315.2773)


   

2-{5-[(2e)-5-[(1r)-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpent-2-en-1-yl]-3h-imidazol-4-yl}ethanamine

2-{5-[(2e)-5-[(1r)-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpent-2-en-1-yl]-3h-imidazol-4-yl}ethanamine

C20H33N3 (315.2674)


   

(1r,11s,13r,14r)-7,19,23-triazahexacyclo[9.9.1.1¹,¹³.1²,⁶.0⁷,²¹.0¹⁴,¹⁹]tricosane

(1r,11s,13r,14r)-7,19,23-triazahexacyclo[9.9.1.1¹,¹³.1²,⁶.0⁷,²¹.0¹⁴,¹⁹]tricosane

C20H33N3 (315.2674)


   

3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16),14-triene-5,14-diol

3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16),14-triene-5,14-diol

C20H29NO2 (315.2198)


   

1-[(1s,3as,3bs,7r,9ar,9bs,11as)-7-amino-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[(1s,3as,3bs,7r,9ar,9bs,11as)-7-amino-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

C21H33NO (315.2562)


   

1-[(1r,3ar,3br,7r,9as,9br,11as)-7-amino-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[(1r,3ar,3br,7r,9as,9br,11as)-7-amino-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

C21H33NO (315.2562)


   

(1r,2s,6s,11r,13s,14s,21s)-7,19,23-triazahexacyclo[9.9.1.1¹,¹³.1²,⁶.0⁷,²¹.0¹⁴,¹⁹]tricosane

(1r,2s,6s,11r,13s,14s,21s)-7,19,23-triazahexacyclo[9.9.1.1¹,¹³.1²,⁶.0⁷,²¹.0¹⁴,¹⁹]tricosane

C20H33N3 (315.2674)


   

(2s)-12-[(2r,5s,6s)-5-hydroxy-6-methylpiperidin-2-yl]dodecane-1,2-diol

(2s)-12-[(2r,5s,6s)-5-hydroxy-6-methylpiperidin-2-yl]dodecane-1,2-diol

C18H37NO3 (315.2773)


   

1-(piperidin-2-yl)-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-2-ene

1-(piperidin-2-yl)-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-2-ene

C20H33N3 (315.2674)


   

12-[(2r,5s,6s)-5-hydroxy-6-methylpiperidin-2-yl]dodecane-1,2-diol

12-[(2r,5s,6s)-5-hydroxy-6-methylpiperidin-2-yl]dodecane-1,2-diol

C18H37NO3 (315.2773)


   

{3-ethyl-16-methyl-1-azapentacyclo[9.6.1.0²,¹⁵.0³,¹².0⁴,⁸]octadec-4-en-12-yl}methanol

{3-ethyl-16-methyl-1-azapentacyclo[9.6.1.0²,¹⁵.0³,¹².0⁴,⁸]octadec-4-en-12-yl}methanol

C21H33NO (315.2562)


   

1-(piperidin-2-yl)-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-7-ene

1-(piperidin-2-yl)-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-7-ene

C20H33N3 (315.2674)


   

n-[(1s,3ar,3a¹r,4s,5as,10ar)-1,4,7,7-tetramethyl-2,3,3a,3a¹,4,5,5a,6,8,9,10,10a-dodecahydropyren-1-yl]carboximidic acid

n-[(1s,3ar,3a¹r,4s,5as,10ar)-1,4,7,7-tetramethyl-2,3,3a,3a¹,4,5,5a,6,8,9,10,10a-dodecahydropyren-1-yl]carboximidic acid

C21H33NO (315.2562)


   

[(2r,3r,8s,11s,12r,15r,16s)-3-ethyl-16-methyl-1-azapentacyclo[9.6.1.0²,¹⁵.0³,¹².0⁴,⁸]octadec-4-en-12-yl]methanol

[(2r,3r,8s,11s,12r,15r,16s)-3-ethyl-16-methyl-1-azapentacyclo[9.6.1.0²,¹⁵.0³,¹².0⁴,⁸]octadec-4-en-12-yl]methanol

C21H33NO (315.2562)


   

3-(2-heptylcyclopropyl)-n-(2-phenylethyl)propanimidic acid

3-(2-heptylcyclopropyl)-n-(2-phenylethyl)propanimidic acid

C21H33NO (315.2562)


   

(2e,4e)-n-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienimidic acid

(2e,4e)-n-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienimidic acid

C20H29NO2 (315.2198)


   

(1r,3e,5s,10r)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16),14-triene-5,14-diol

(1r,3e,5s,10r)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16),14-triene-5,14-diol

C20H29NO2 (315.2198)


   

n-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienimidic acid

n-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienimidic acid

C20H29NO2 (315.2198)


   

12-(5-hydroxy-6-methylpiperidin-2-yl)dodecane-1,2-diol

12-(5-hydroxy-6-methylpiperidin-2-yl)dodecane-1,2-diol

C18H37NO3 (315.2773)


   

1-{7-amino-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethanone

1-{7-amino-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethanone

C21H33NO (315.2562)


   

7,19,23-triazahexacyclo[9.9.1.1¹,¹³.1²,⁶.0⁷,²¹.0¹⁴,¹⁹]tricosane

7,19,23-triazahexacyclo[9.9.1.1¹,¹³.1²,⁶.0⁷,²¹.0¹⁴,¹⁹]tricosane

C20H33N3 (315.2674)


   

(1s,7r,9r,10s)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-2-ene

(1s,7r,9r,10s)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-2-ene

C20H33N3 (315.2674)


   

1-[(1s,3as,3bs,7r,9ar,9bs,11ar)-7-amino-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[(1s,3as,3bs,7r,9ar,9bs,11ar)-7-amino-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

C21H33NO (315.2562)


   

(1s,2s,9r,10s)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-7-ene

(1s,2s,9r,10s)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-7-ene

C20H33N3 (315.2674)


   

(1s,2s,9s,10r)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-7-ene

(1s,2s,9s,10r)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-7-ene

C20H33N3 (315.2674)


   

3-[(1s,2s)-2-heptylcyclopropyl]-n-(2-phenylethyl)propanimidic acid

3-[(1s,2s)-2-heptylcyclopropyl]-n-(2-phenylethyl)propanimidic acid

C21H33NO (315.2562)


   

3-[(1r,2r)-2-heptylcyclopropyl]-n-(2-phenylethyl)propanimidic acid

3-[(1r,2r)-2-heptylcyclopropyl]-n-(2-phenylethyl)propanimidic acid

C21H33NO (315.2562)


   

(1r,2s,6r,11s,13r,14r,21r)-7,19,23-triazahexacyclo[9.9.1.1¹,¹³.1²,⁶.0⁷,²¹.0¹⁴,¹⁹]tricosane

(1r,2s,6r,11s,13r,14r,21r)-7,19,23-triazahexacyclo[9.9.1.1¹,¹³.1²,⁶.0⁷,²¹.0¹⁴,¹⁹]tricosane

C20H33N3 (315.2674)